Sector--
Established Date20/05/2021
Listing Date08/03/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees6
Fiscal Year Ends31/12
Security TypeCommon stock
Office address68 Cummings Park Drive, Woburn, MA 01801
Business
IntroductionAbpro Holdings, Inc., was incorporated in Delaware on May 20, 2021. The company is a biotechnology company focused on developing next-generation antibody therapies designed to improve the lives of patients with serious and life-threatening diseases. Abpro focuses on novel antibody construction in immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, Abpro is developing a next-generation antibody pipeline independently or through collaborations with global pharmaceutical and research institutions.
